| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 662413 | 70572 | APIRETAL 500 mg COMPRIMIDOS BUCODISPERSABLES | APIRETAL 500 mg COMPRIMIDOS BUCODISPERSABLES, 24 comprimidos | 500 mg | 5 | 24 | 10 | 24 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70572/70572_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70572/70572_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 2009-02-20 | 1 | 1 | 1 | 2009-02-20 | 2009-02-20 | 1 | 2018-06-11 | View Edit Delete | ||||||||||||
| 656565 | 68004 | APIROFENO 40 mg/ml SUSPENSION ORAL | APIROFENO 40 mg/ml SUSPENSION ORAL , 1 frasco de 150 ml | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68004/68004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68004/68004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 2006-08-29 | 1 | 1 | 1 | 2006-08-29 | 2007-07-02 | 1 | 2011-09-09 | 655964 | View Edit Delete | |||||||||||
| 710175 | 68004 | APIROFENO 40 mg/ml SUSPENSION ORAL | APIROFENO 40 mg/ml SUSPENSION ORAL , 1 frasco de 200 ml | 40 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68004/68004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68004/68004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 2006-08-29 | 1 | 1 | 1 | 2006-08-29 | 2016-02-24 | 1 | 2016-06-16 | View Edit Delete | ||||||||||||
| 664267 | 68004 | APIROFENO 40 mg/ml SUSPENSION ORAL | APIROFENO 40 mg/ml SUSPENSION ORAL , 1 frasco de 50 ml | 40 mg/ml | 6 | 50 | 26 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68004/68004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68004/68004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 2006-08-29 | 1 | 1 | 1 | 2006-08-29 | 2009-11-19 | 1 | 2011-09-09 | View Edit Delete | ||||||||||||
| 614552 | 45432 | APIROSERUM CLORURO SODICO 2% SOLUCIÓN PARA PERFUSION | APIROSERUM CLORURO SODICO 2% SOLUCIÓN PARA PERFUSION, 12 frascos de 500 ml | 2% | 6 | 12 | 48 | 12 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/45432/45432_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/45432/45432_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1968-01-01 | 1 | 1 | 1 | 1968-01-01 | 1970-10-01 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 614958 | 49869 | APIROSERUM GLUCOSALINO 1/5 SOLUCIÓN PARA PERFUSIÓN | APIROSERUM GLUCOSALINO 1/5 SOLUCIÓN PARA PERFUSIÓN, 12 frascos de 250 ml | 5% + 0,2% | 69 | 12 | 48 | 12 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49869/49869_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49869/49869_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1972-10-01 | 1 | 1 | 1 | 1972-10-01 | 1982-06-01 | 0 | 2011-02-09 | View Edit Delete | ||||||||||||
| 615047 | 49869 | APIROSERUM GLUCOSALINO 1/5 SOLUCIÓN PARA PERFUSIÓN | APIROSERUM GLUCOSALINO 1/5 SOLUCIÓN PARA PERFUSIÓN, 12 frascos de 500 ml | 5% + 0,2% | 69 | 12 | 48 | 12 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49869/49869_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49869/49869_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1972-10-01 | 1 | 1 | 1 | 1972-10-01 | 1982-06-01 | 0 | 2011-02-09 | View Edit Delete | ||||||||||||
| 614602 | 45434 | APIROSERUM NORMAION RESTAURADOR | APIROSERUM NORMAION RESTAURADOR , 12 frascos de 500 ml | N/A (más de 4 PA) | 69 | 12 | 48 | 12 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/45434/45434_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/45434/45434_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1968-11-01 | 1 | 1 | 1 | 1968-11-01 | 1968-12-01 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 703421 | 63893 | APO-GO PEN 10 mg/ml SOLUCION INYECTABLE | APO-GO PEN 10 mg/ml SOLUCION INYECTABLE , 5 plumas precargadas de 3 ml | 10 mg/ml inyectable 3 ml | 12 | 5 | 49 | 5 plumas precargadas de 3 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63893/63893_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63893/63893_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2787 | ITALFARMACO S.A. | 2001-05-17 | 1 | 1 | 1 | 2001-05-17 | 2001-05-17 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 681975 | 74401 | APO-GO PFS 5 mg/ml SOLUCION PARA PERFUSION EN JERINGA PRECARGADA | APO-GO PFS 5 mg/ml SOLUCION PARA PERFUSION EN JERINGA PRECARGADA , 5 jeringas precargadas de 10 ml | 5 mg/ml inyectable 10 ml | 33 | 5 | 61 | 5 jeringas precargadas de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74401/74401_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74401/74401_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2787 | ITALFARMACO S.A. | 2011-11-24 | 1 | 1 | 1 | 2011-11-24 | 2011-11-24 | 1 | 2012-10-09 | View Edit Delete | ||||||||||||
| 729379 | 85464 | APO-GO POD 5 MG/ML SOLUCION PARA PERFUSION EN CARTUCHO | APO-GO POD 5 MG/ML SOLUCION PARA PERFUSION EN CARTUCHO, 5 cartuchos de 20 ml | 5 mg/ml inyectable 20 ml | 12 | 5 | 57 | 5 cartuchos de 20 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85464/85464_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85464/85464_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2787 | ITALFARMACO S.A. | 2020-11-27 | 1 | 1 | 1 | 2020-11-27 | 2020-11-27 | 1 | 2024-07-12 | View Edit Delete | ||||||||||||
| 976258 | 57514 | APOCARD 10 mg/ml SOLUCION INYECTABLE | APOCARD 10 mg/ml SOLUCION INYECTABLE, 5 ampollas de 15 ml | 10 mg/ml inyectable 15 ml | 1 | 5 | 1 | 5 ampollas de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57514/57514_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57514/57514_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 1988-01-01 | 1 | 1 | 1 | 1988-01-01 | 1988-01-01 | 1 | 2011-03-30 | View Edit Delete | ||||||||||||
| 859991 | 57532 | APOCARD 100 mg COMPRIMIDOS | APOCARD 100 mg COMPRIMIDOS , 30 comprimidos | 100 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57532/57532_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57532/57532_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 1988-01-01 | 1 | 1 | 1 | 1988-01-01 | 2000-05-26 | 1 | 2011-03-30 | View Edit Delete | ||||||||||||
| 860213 | 57532 | APOCARD 100 mg COMPRIMIDOS | APOCARD 100 mg COMPRIMIDOS , 60 comprimidos | 100 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57532/57532_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57532/57532_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 1988-01-01 | 1 | 1 | 1 | 1988-01-01 | 2000-05-26 | 1 | 2011-03-30 | View Edit Delete | ||||||||||||
| 759980 | 88396 | APODEV 5 MG/ML SOLUCIÓN PARA PERFUSIÓN EFG | APODEV 5 MG/ML SOLUCIÓN PARA PERFUSIÓN EFG, 1 vial de 20 ml | 5 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88396/88396_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88396/88396_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28717 | VEGAL FARMACEUTICA S.L. | 2022-12-15 | 1 | 1 | 1 | 2022-12-16 | 2022-12-15 | 1 | 2023-12-15 | View Edit Delete | ||||||||||||
| 661638 | 70136 | APOGAR 5MG/5MG COMPRIMIDOS PARA CHUPAR | APOGAR 5MG/5MG COMPRIMIDOS PARA CHUPAR , 20 comprimidos | 5 mg/5 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70136/70136_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70136/70136_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2008-10-10 | 1 | 1 | 1 | 2008-10-10 | 2008-10-10 | 1 | 2014-06-24 | View Edit Delete | ||||||||||||
| 650829 | 66617 | APOGRIP POLVO PARA SOLUCION ORAL | APOGRIP POLVO PARA SOLUCION ORAL, 10 sobres | 650 mg/4 mg/10 mg | 35 | 10 | 64 | 10 sobres | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66617/66617_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66617/66617_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2005-02-15 | 1 | 1 | 1 | 2005-02-15 | 2005-02-15 | 1 | 2011-04-14 | View Edit Delete | ||||||||||||
| 828509 | 64999 | APOXOL 3 MG/ML JARABE EFG | APOXOL 3 MG/ML JARABE EFG , 1 frasco de 200 ml | 3 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64999/64999_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64999/64999_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2002-09-23 | 1 | 1 | 1 | 2002-09-23 | 2002-09-23 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 726467 | 84388 | APREDONAV 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | APREDONAV 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84388/84388_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84388/84388_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28186 | MEDOCHEMIE IBERIA S.A. SUCURSAL EN ESPANA | 2019-07-29 | 1 | 1 | 1 | 2019-07-30 | 2019-07-29 | 1 | 2022-10-26 | View Edit Delete | ||||||||||||
| 726468 | 84389 | APREDONAV 7,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | APREDONAV 7,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 7,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84389/84389_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84389/84389_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28186 | MEDOCHEMIE IBERIA S.A. SUCURSAL EN ESPANA | 2019-07-29 | 1 | 1 | 1 | 2019-07-30 | 2019-07-29 | 1 | 2022-10-26 | View Edit Delete |
Page 78 of 1035, showing 20 records out of 20697 total, starting on record 1541, ending on 1560